Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

M-Vax nearing commercialization in several markets

Sep. 16, 1999

Genzyme Molecular Oncology announces initiation of breast cancer vaccine trial

Sep. 16, 1999

Transgene commences phase I trial for treatment of cervical cancer

Sep. 14, 1999

Maxamine treatment leads to tumor regression in preclinical model of prostate cancer

Sep. 14, 1999

LifeTime and Arkios enter oncology alliance

Sep. 13, 1999

Biomira revises collaboration with Chiron for Theratope vaccine

Sep. 7, 1999

Beta LT demonstrates positive results in initial human trials

Sep. 7, 1999

First patient enrolled in York Medical's cancer vaccine trial

Sep. 6, 1999

Immunomedics awarded four grants from the NIH for development of cancer therapies

Sep. 6, 1999

Maxamine combination treatment for AML effective in phase II studies

Sep. 6, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 18, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 18, 2025.
Maintenance, man: Lilly’s phase III weight trial hits goals
BioWorld
Eli Lilly and Co. took another step toward adding a way for patients to hang onto their weight loss when the firm disclosed positive top-line data from the phase...
AI drug developer Insilico to raise $292 million in Hong Kong IPO
BioWorld
Insilico Medicine Inc. plans to raise HK$2.27 billion (US$292 million) in its IPO on the Hong Kong Securities Exchange to advance its clinical pipeline and invest...